Production (Stage)
Zymeworks Inc.
ZYME
$11.54
$0.060.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.11M | 31.03M | 16.00M | 19.24M | 10.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.11M | 31.03M | 16.00M | 19.24M | 10.03M |
| Cost of Revenue | 35.74M | 37.06M | 36.35M | 29.16M | 32.74M |
| Gross Profit | -8.63M | -6.03M | -20.35M | -9.92M | -22.71M |
| SG&A Expenses | 16.99M | 16.19M | 13.85M | 15.68M | 15.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.72M | 53.25M | 50.21M | 44.84M | 48.53M |
| Operating Income | -25.61M | -22.22M | -34.21M | -25.60M | -38.50M |
| Income Before Tax | -22.14M | -17.79M | -29.62M | -37.62M | -31.58M |
| Income Tax Expenses | 496.00K | 5.72M | 226.00K | 68.00K | 75.00K |
| Earnings from Continuing Operations | -22.64M | -23.51M | -29.85M | -37.69M | -31.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.64M | -23.51M | -29.85M | -37.69M | -31.65M |
| EBIT | -25.61M | -22.22M | -34.21M | -25.60M | -38.50M |
| EBITDA | -23.02M | -19.22M | -32.19M | -23.69M | -36.74M |
| EPS Basic | -0.30 | -0.31 | -0.39 | -0.49 | -0.42 |
| Normalized Basic EPS | -0.18 | -0.15 | -0.24 | -0.17 | -0.26 |
| EPS Diluted | -0.30 | -0.31 | -0.39 | -0.49 | -0.42 |
| Normalized Diluted EPS | -0.18 | -0.15 | -0.24 | -0.17 | -0.26 |
| Average Basic Shares Outstanding | 75.17M | 74.66M | 76.13M | 76.39M | 76.21M |
| Average Diluted Shares Outstanding | 75.23M | 74.72M | 76.16M | 76.40M | 76.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |